What is MedDev?
MedDev Corporation stands as a global innovator in supportive eye care devices, focusing on solutions for patients experiencing difficulties in fully closing their eyelids, often due to facial palsy. With a legacy spanning over five decades, MedDev offers a comprehensive suite of both surgical and non-surgical interventions, including advanced eyelid weight implants and external lid weights. The company actively engages with key opinion leaders to pioneer new technologies, ensuring its product portfolio remains at the cutting edge of ophthalmic care. MedDev's commitment is to provide immediate, non-invasive support and definitive treatments aimed at mitigating the risks associated with ocular exposure.
How much funding has MedDev raised?
MedDev has raised a total of $100K across 1 funding round:
Debt
$100K
Debt (2021): $100K with participation from PPP
Key Investors in MedDev
PPP
Public-Private Partnership
What's next for MedDev?
The substantial backing indicated by $100K suggests MedDev is in a mature phase of its corporate lifecycle, likely leveraging this capital for continued market expansion, research and development into next-generation eye care technologies, and potentially strategic acquisitions. The recent strategic investment, coupled with the company's long-standing experience, positions MedDev to further solidify its leadership in the supportive eye care device market and address the evolving needs of patients worldwide.
See full MedDev company page
